Company Snapshot
- Ticker
- TMO
- Name
- TMO
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 217693980000.000000
- Volume
- 1,566,790
- Avg Volume (3M)
- 1,931,843
TMO
TMO
Last update recent
575.91
+3.63
(+0.63%)
Market Cap
217693980000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 43736000000.000000
- EPS
- 17.34
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.29%
- Net Income
- 6570000000.000000
- Net Margin
- 15.02%
- Payout Ratio
- 9.48%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 33.13
- Forward P/E
- None
- P/S
- 4.98
- P/B
- 4.26
- Beta
- None
- Debt / Equity
- 0.70
- Current Ratio
- 1.50
- Return on Equity
- 0.13%
- Return on Assets
- 0.06%
Technicals & Returns
- Distance vs 200 DMA
- 19.56%
- 200 DMA
- 481.70
- Distance vs 50 DMA
- 1.9%
- 50 DMA
- 565.17
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic Read more
- Name
- TMO
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Marc N. Casper
- Employees
- 122,000
- IPO Date
- 1980-03-17
- Phone
- 781 622 1000
- Address
- None
- Website
- https://www.thermofisher.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-09-13 • $0.39
Latest News
Curated headlines from premium sources.
OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy
LOS ANGELES--(BUSINESS WIRE)--OlivePoint acquires a Class A Raleigh office 100% leased to PPD/Thermo Fisher, highlighting its strategy to target mispriced, cre…
Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM…
B. Riley Wealth Advisors Inc. Purchases New Shares in Thermo Fisher Scientific Inc. $TMO
B. Riley Wealth Advisors Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the second quarter, according to the company in its most re…
Thermo Fisher Scientific Inc. $TMO is BlueSpruce Investments LP’s 9th Largest Position
BlueSpruce Investments LP boosted its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 18.2% during the second quarter, according to the company…
First Look: Lululemon shake-up, Broadcom AI jitters, Costco beat
Stock News Lululemon leadership change lifts shares: Lululemon Athletica (LULU) said CEO Calvin McDonald will step down Jan. 31, with CFO Meghan Frank and CCO A
Bayesian Capital Management LP Buys 5,800 Shares of Thermo Fisher Scientific Inc. $TMO
Bayesian Capital Management LP raised its stake in Thermo Fisher Scientific Inc. (NYSE: TMO) by 527.3% in the second quarter, according to the company in its m…